# ZNF132

## Overview
ZNF132 is a gene that encodes the zinc finger protein 132, a member of the zinc finger protein family, which is characterized by the presence of zinc finger motifs. These motifs are crucial for the protein's role as a transcription factor, enabling it to bind specific DNA sequences and regulate gene expression. Zinc finger protein 132 is predominantly localized in the nucleus, where it influences various cellular processes, including cell differentiation and development, by modulating the transcriptional activity of target genes. The gene's expression is subject to epigenetic regulation, particularly through promoter methylation, which can impact its role in cancer progression. The protein's involvement in transcriptional regulation and its potential tumor suppressor functions underscore its significance in both normal cellular function and disease states (Jiang2018Epigenetic; Liu2021Downregulated).

## Structure
ZNF132, a member of the zinc finger protein family, is characterized by the presence of zinc finger domains. These domains are small protein structural motifs stabilized by zinc ions, which facilitate binding to DNA, RNA, or other proteins. The primary structure of ZNF132 consists of amino acid sequences that form these zinc finger motifs. The secondary structure of ZNF132 often includes alpha helices and beta sheets, which contribute to the stability and function of the protein. The tertiary structure involves the overall 3D folding of the protein, which is crucial for its interaction with other molecules. While the quaternary structure refers to the assembly of multiple protein subunits, it is not specified if ZNF132 forms such structures.

Post-translational modifications such as phosphorylation or ubiquitination may regulate the function of ZNF132, although specific modifications are not detailed. Splice variant isoforms of ZNF132 can result in different functional or structural properties, potentially affecting its role in cellular processes. These structural features and modifications are essential for the diverse functions of ZNF132 in the cell, particularly in gene regulation and interaction with nucleic acids.

## Function
ZNF132, a member of the zinc finger protein family, plays a crucial role in regulating gene expression through its function as a transcription factor. This protein is characterized by the presence of zinc finger motifs, which enable it to bind to specific DNA sequences, thereby influencing the transcriptional activity of target genes. ZNF132 is predominantly active in the nucleus, where it modulates the transcriptional landscape of the cell, impacting various cellular processes such as cell differentiation and development.

In healthy human cells, ZNF132 contributes to the regulation of genes involved in essential biological processes. By controlling the expression of these genes, ZNF132 helps maintain normal cellular functions and supports the proper development and differentiation of cells. Its activity is integral to ensuring that cells respond appropriately to developmental cues and environmental signals, which is vital for maintaining cellular homeostasis and function. The precise regulation of gene expression by ZNF132 is essential for the orderly progression of cellular events, underscoring its importance in cell biology and organismal development.

## Clinical Significance
The ZNF132 gene has been implicated in several types of cancer due to its downregulation through promoter hypermethylation, which is a common epigenetic alteration that silences tumor suppressor genes. In breast cancer, ZNF132 is downregulated, and this reduction in expression is associated with shorter relapse-free survival, suggesting its potential as a prognostic marker (Liu2021Downregulated). Similarly, in prostate cancer, ZNF132 is downregulated, particularly in metastatic and castrate-refractory cases, and is linked to poor prognosis and early PSA recurrence. However, its independent prognostic value is limited when considering other clinical factors (Abildgaard2011Downregulation).

In esophageal squamous cell carcinoma (ESCC), ZNF132 is epigenetically silenced through hypermethylation, which inhibits the binding of the transcription factor Sp1, leading to reduced gene expression. This silencing is associated with cancer progression, and overexpression of ZNF132 in ESCC cells has been shown to inhibit cell proliferation, migration, and promote apoptosis, indicating its role as a tumor suppressor (Jiang2018Epigenetic). In lung adenocarcinomas, particularly 'pan-negative' types, ZNF132 hypermethylation is linked to clinicopathological aggressiveness, suggesting its potential as a biomarker for cancer aggressiveness (Hamada2020DNA).

## Interactions
ZNF132, a zinc finger protein, is involved in interactions with nucleic acids and other proteins, primarily through its role in transcriptional regulation. One of the key interactions of ZNF132 is with the transcription factor Sp1. This interaction is crucial for the regulation of ZNF132 expression, as Sp1 binds to the promoter region of the ZNF132 gene. However, this binding is sensitive to methylation; when the promoter region is hypermethylated, Sp1's binding affinity is reduced, leading to decreased transcriptional activity of ZNF132 (Jiang2018Epigenetic).

The methylation-sensitive binding of Sp1 to the ZNF132 promoter suggests that ZNF132 is part of a regulatory network where its expression is modulated by epigenetic changes. This interaction highlights the potential role of ZNF132 in cancer progression, as its silencing through promoter hypermethylation is associated with various cancers, including esophageal squamous cell carcinoma and breast cancer (Jiang2018Epigenetic; Liu2021Downregulated).

While specific protein-protein interactions involving ZNF132 are not detailed in the provided context, its interaction with Sp1 and the impact of methylation on this interaction underscore its involvement in transcriptional regulation and epigenetic modulation.


## References


[1. (Jiang2018Epigenetic) Dong Jiang, Zhenglei He, Chenji Wang, Yinghui Zhou, Fang Li, Weilin Pu, Xueqing Zhang, Xulong Feng, Meng Zhang, Xinyue Yecheng, Yunyun Xu, Li Jin, Shicheng Guo, Jiucun Wang, and Minghua Wang. Epigenetic silencing of znf132 mediated by methylation-sensitive sp1 binding promotes cancer progression in esophageal squamous cell carcinoma. Cell Death &amp; Disease, December 2018. URL: http://dx.doi.org/10.1038/s41419-018-1236-z, doi:10.1038/s41419-018-1236-z. This article has 153 citations.](https://doi.org/10.1038/s41419-018-1236-z)

[2. (Abildgaard2011Downregulation) Mette Opstrup Abildgaard, Michael Borre, Martin Mørck Mortensen, Benedicte P. Ulhøi, Niels Tørring, Peter Wild, Helle Kristensen, Francisco Mansilla, Peter D. Ottosen, Lars Dyrskjøt, Torben F. Ørntoft, and Karina Dalsgaard Sørensen. Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis. International Journal of Cancer, 130(4):885–895, May 2011. URL: http://dx.doi.org/10.1002/ijc.26097, doi:10.1002/ijc.26097. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.26097)

[3. (Liu2021Downregulated) Zhao Liu, Jiaxin Liu, Ruimiao Liu, Man Xue, Weifan Zhang, Xinhui Zhao, Jiang Zhu, and Peng Xia. Downregulated znf132 predicts unfavorable outcomes in breast cancer via hypermethylation modification. BMC Cancer, April 2021. URL: http://dx.doi.org/10.1186/s12885-021-08112-z, doi:10.1186/s12885-021-08112-z. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-021-08112-z)

[4. (Hamada2020DNA) Kenichi Hamada, Ying Tian, Mao Fujimoto, Yoriko Takahashi, Takashi Kohno, Koji Tsuta, Shun-ichi Watanabe, Teruhiko Yoshida, Hisao Asamura, Yae Kanai, and Eri Arai. Dna hypermethylation of the znf132 gene participates in the clinicopathological aggressiveness of ‘pan-negative’-type lung adenocarcinomas. Carcinogenesis, 42(2):169–179, November 2020. URL: http://dx.doi.org/10.1093/carcin/bgaa115, doi:10.1093/carcin/bgaa115. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/carcin/bgaa115)